Join Boehringer Ingelheim to network with other bio-entrepreneurs as well as hear from scientific and commercial leaders as they discuss some of the implications of the financial downturn such as when to seek pharma investment or pharma collaboration - growing alternatives to traditional biopharma fundraising.

Learn more and register here.